Insulet Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Insulet Corp Unternehmen

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Insulet Corp Informationen



BörsenkürzelPODD

Name des UnternehmensInsulet Corp

IPO-datumMay 15, 2007

CEOMs. Ashley Mcevoy

Anzahl der mitarbeiter3900

WertpapierartOrdinary Share

GeschäftsjahresendeMay 15

Addresse100 Nagog Park

StadtACTON

BörseNASDAQ Global Select Consolidated

LandUnited States of America

Postleitzahl01720-3440

Telefon19786007000

Websitehttps://www.omnipod.com

BörsenkürzelPODD

IPO-datumMay 15, 2007

CEOMs. Ashley Mcevoy

Führungskräfte von Insulet Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

--

Mr. Prem Singh

Senior Vice President - Global Operations

3.56K

-16.16%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

14.85K

-8.50%

Mr. Eric Benjamin

Chief Operating Officer

10.47K

-28.94%

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Nach RegionUSD

Name

Umsatz

Anteil

United States

463.30M

71.38%

All Other

185.80M

28.62%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

U.S.Omnipod

453.20M

69.82%

International Omnipod

185.80M

28.62%

Drug Delivery

10.20M

1.57%

Aktionärsstatistik

Aktualisiert: Tue, Aug 19

Aktionäre

Aktionärstypen

Aktionäre

Anteil

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Andere

60.68%

Aktionäre

Anteil

The Vanguard Group, Inc.

12.33%

Fidelity Management & Research Company LLC

9.74%

Capital Research Global Investors

6.73%

BlackRock Institutional Trust Company, N.A.

6.18%

State Street Investment Management (US)

4.34%

Andere

60.68%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

64.61%

Investment Advisor/Hedge Fund

23.75%

Hedge Fund

5.78%

Research Firm

2.96%

Pension Fund

2.15%

Sovereign Wealth Fund

1.60%

Bank and Trust

1.22%

Individual Investor

0.30%

Private Equity

0.09%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

1522

71.86M

102.08%

-3.62M

2025Q2

1541

72.80M

103.47%

-3.81M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

The Vanguard Group, Inc.

8.68M

12.33%

+38.89K

+0.45%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.86M

9.74%

-271.19K

-3.80%

Jun 30, 2025

Capital Research Global Investors

4.74M

6.73%

-1.34M

-22.06%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

4.35M

6.18%

-13.40K

-0.31%

Jun 30, 2025

State Street Investment Management (US)

3.06M

4.34%

+32.74K

+1.08%

Jun 30, 2025

Baillie Gifford & Co.

2.14M

3.03%

-115.69K

-5.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.93M

2.74%

+58.31K

+3.12%

Jun 30, 2025

ClearBridge Investments, LLC

1.54M

2.18%

+56.63K

+3.83%

Jun 30, 2025

American Century Investment Management, Inc.

1.31M

1.86%

+157.07K

+13.63%

Jun 30, 2025

Fidelity International

1.13M

1.61%

-155.38K

-12.09%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Mon, Oct 6

Name

Anteil

Langar Global HealthTech ETF

6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.97%

Goldman Sachs Future Health Care Equity ETF

4.91%

Global X HealthTech ETF

4.42%

Fidelity Digital Health ETF

4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

3.4%

Congress SMid Growth ETF

2.99%

iShares U.S. Medical Devices ETF

2.74%

iShares Health Innovation Active ETF

2.64%

FT Raymond James Multicap Growth Equity ETF

2.54%

Langar Global HealthTech ETF

Anteil6.89%

First Trust Nasdaq Lux Digi Health Solutions ETF

Anteil4.97%

Goldman Sachs Future Health Care Equity ETF

Anteil4.91%

Global X HealthTech ETF

Anteil4.42%

Fidelity Digital Health ETF

Anteil4.3%

Invesco Dorsey Wright Healthcare Momentum ETF

Anteil3.4%

Congress SMid Growth ETF

Anteil2.99%

iShares U.S. Medical Devices ETF

Anteil2.74%

iShares Health Innovation Active ETF

Anteil2.64%

FT Raymond James Multicap Growth Equity ETF

Anteil2.54%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten